Hosny, M.; Verkleij, C.P.M.; van der Schans, J.; Frerichs, K.A.; Mutis, T.; Zweegman, S.; van de Donk, N.W.C.J.
Current State of the Art and Prospects of T Cell-Redirecting Bispecific Antibodies in Multiple Myeloma. J. Clin. Med. 2021, 10, 4593.
https://doi.org/10.3390/jcm10194593
AMA Style
Hosny M, Verkleij CPM, van der Schans J, Frerichs KA, Mutis T, Zweegman S, van de Donk NWCJ.
Current State of the Art and Prospects of T Cell-Redirecting Bispecific Antibodies in Multiple Myeloma. Journal of Clinical Medicine. 2021; 10(19):4593.
https://doi.org/10.3390/jcm10194593
Chicago/Turabian Style
Hosny, Mashhour, Christie P. M. Verkleij, Jort van der Schans, Kristine A. Frerichs, Tuna Mutis, Sonja Zweegman, and Niels W. C. J. van de Donk.
2021. "Current State of the Art and Prospects of T Cell-Redirecting Bispecific Antibodies in Multiple Myeloma" Journal of Clinical Medicine 10, no. 19: 4593.
https://doi.org/10.3390/jcm10194593
APA Style
Hosny, M., Verkleij, C. P. M., van der Schans, J., Frerichs, K. A., Mutis, T., Zweegman, S., & van de Donk, N. W. C. J.
(2021). Current State of the Art and Prospects of T Cell-Redirecting Bispecific Antibodies in Multiple Myeloma. Journal of Clinical Medicine, 10(19), 4593.
https://doi.org/10.3390/jcm10194593
